Replies to post #126274 on Biotech Values

[DewDiligence]

New survey on the purpose of DNDN’s 9/8/11 CC:

Q: Which of the following comes closest to your opinion
on what will be announced at the 9/8/11 conference call?


a) DNDN is cutting the price of Provenge.

b) DNDN has engaged an investment bank to explore “strategic options.”

c) DNDN is shutting down operations and returning surplus cash to shareholders.

d) David Miller is replacing Mitch Gold as CEO.


To vote, please go to
http://www.investorshub.com/boards/board_surveymenu.asp?board_id=1418
and select survey #141.

Note: You may vote in any listed survey in which you have not already voted.